COPD control: Can a consensus be found?
Author:
Funder
Novartis Portugal
Publisher
Elsevier BV
Reference86 articles.
1. Characterisation of COPD heterogeneity in the ECLIPSE cohort;Agusti;Respir Res,2010
2. Outcomes for COPD pharmacological trials: from lung function to biomarkers;Cazzola;Eur Respir J,2008
3. Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease;Schlecht;Chron Respir Dis,2005
4. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD;Nishimura;Chest,2002
5. Disease severity and symptoms among patients receiving monotherapy for COPD;Dransfield;Prim Care Respir J,2011
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Chronic Obstructive Pulmonary Disease: Constraints in Patient Pathway and Mitigation Strategies;Portuguese Journal of Public Health;2024
2. Evaluating Influenza Vaccination Practices among COPD Patients;Vaccines;2023-12-22
3. Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option;International Journal of Chronic Obstructive Pulmonary Disease;2023-07
4. Prevention as a prominent self-management strategy in men with chronic obstructive pulmonary disease: A qualitative study;Journal of Human Behavior in the Social Environment;2023-03-08
5. Future concepts in bronchodilation for COPD: dual- versus monotherapy;European Respiratory Review;2021-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3